Fludeoxyglucose F 18 Injection Recalled for Lack of Sterility Assurance
The General Hospital Corporation is recalling Fludeoxyglucose F 18 Injection due to a lack of assurance of sterility. The product was distributed to one direct account.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible health consequences. The source text does not report any illnesses or injuries, and the hazard is a lack of assurance of sterility rather than a confirmed contamination event, fitting the criteria for a moderate severity score.
Plain-English summary
The General Hospital Corporation is recalling Fludeoxyglucose F 18 Injection, a prescription radiopharmaceutical used for diagnostic imaging. The recall was initiated because of a lack of assurance of sterility for the product.
The affected product is identified as Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, packaged in 50 mL glass vials. The specific lot number is P01-021721, with an expiration date of 02/17/2021. The product was manufactured by Massachusetts General Hospital PET Center in Boston, MA.
The recall is limited to one direct account. No specific instructions for consumers are provided in the source text, as the product is a prescription drug distributed to a medical facility.
The recalled product
- Product
- FLUDEOXYGLUCOSE F 18 (FLUDEOXYGLUCOSE F-18)
- Brand
- FLUDEOXYGLUCOSE F 18
- Manufacturer
- The General Hospital Corporation
- Category
- Drug — Radiopharmaceutical
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # P01-021721
- exp 02/17/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29